Our Pricing

Buy Wegovy Online with Private Prescription - No GP Wait

Published on: June 03, 2026

When you buy Wegovy online with a UK private prescription, you can access this MHRA-licensed weight loss treatment without NHS waiting lists. At Cured Pharmacy, our UK-registered prescribers assess your suitability in under 3 minutes, with transparent pricing from £79.00 and discreet next-day delivery across the UK.

How Wegovy Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1 in your body [1]. This medication works by slowing gastric emptying, reducing appetite signals in the brain, and improving blood sugar regulation—three mechanisms that work together to support sustained weight reduction.

In the landmark STEP 1 trial, adults using Wegovy alongside lifestyle modifications achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [1]. Participants also experienced improvements in cardiovascular risk markers including blood pressure, cholesterol levels, and HbA1c measurements [2].

Wegovy is administered as a once-weekly subcutaneous injection, starting at a low dose of 0.25mg and gradually increasing over 16-20 weeks to the maintenance dose of 2.4mg weekly [3]. This titration schedule, overseen by your UK prescriber, minimises gastrointestinal side effects whilst your body adjusts to the medication.

Who Can Buy Wegovy Online with Private Prescription

Wegovy is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3]. Your online consultation with our UK prescribers will assess your medical history, current medications, and weight loss goals to determine suitability.

The medication is not suitable for everyone. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastroparesis, or pregnancy [4]. Our clinical team, led by superintendent pharmacist Tarun Kumar (GPhC 2233073), reviews every assessment to ensure safe prescribing aligned with MHRA and NICE guidelines.

Clinical Assessment Process

Your free online consultation takes under 3 minutes and covers your weight history, previous weight loss attempts, current health conditions, and any medications you're taking. Our UK-registered prescribers review your responses within hours, and if Wegovy is clinically appropriate, your prescription is issued and dispensed from our GPhC-registered pharmacy (9012511) for discreet delivery.

Wegovy Pricing and What's Included

At Cured Pharmacy, Wegovy is available from £79.00 per pen with transparent upfront pricing—you'll see the exact cost before completing your consultation. This price includes your medication, UK prescriber assessment, and discreet packaging with tracked delivery across the UK.

We guarantee the lowest prices in the UK for genuine, licensed medicines. Unlike some services that add hidden consultation fees or subscription charges, our pricing is straightforward: what you see during your assessment is what you pay. Each Wegovy pen contains four doses for once-weekly administration, and your prescriber will confirm the appropriate dose strength based on your current titration stage.

Your first prescription typically covers your initial titration period, with follow-up prescriptions arranged as you progress through dose escalation. Our clinical team monitors your response and adjusts your treatment plan accordingly, ensuring you receive optimal support throughout your weight loss journey.

Price Comparison with Other Weight Loss Treatments

Wegovy represents the most extensively studied semaglutide formulation for weight management, with four major STEP trials demonstrating consistent efficacy across diverse patient populations [1][2]. Whilst other GLP-1 treatments exist, Wegovy's 2.4mg weekly dose is specifically optimised for weight loss rather than diabetes management, which explains the clinical outcomes observed in trials.

Starting Your Wegovy Treatment Online

Beginning Wegovy through Cured Pharmacy is straightforward. Click 'Start Assessment' to complete your free online consultation—our clinical questions cover your medical history, weight goals, and any conditions that might affect treatment suitability. Most patients complete this in under 3 minutes from any device.

Once submitted, a UK-registered prescriber reviews your assessment, typically within a few hours during working days. If Wegovy is appropriate for you, your prescription is issued immediately and sent to our dispensary. We source only genuine UK-licensed Wegovy pens directly from authorised wholesalers, ensuring medication authenticity and proper cold-chain storage.

Your medication is dispatched in discreet, temperature-controlled packaging with next-day tracked delivery across the UK. Each package includes full patient information leaflets, injection technique guidance, and details for ongoing clinical support. You'll also receive follow-up reminders when it's time to reorder or progress to your next dose strength.

What to Expect in Your First Month

During the initial four weeks on Wegovy 0.25mg, most patients notice reduced appetite and earlier satiety at meals [3]. Some experience mild nausea or digestive changes as your body adapts—these effects typically diminish within 1-2 weeks. Your prescriber will confirm when to increase to the 0.5mg dose, usually after four weeks on the starting dose, following the licensed titration schedule.

Clinical Evidence Behind Wegovy

The STEP clinical trial programme represents one of the most comprehensive weight loss medication research efforts conducted to date, enrolling over 4,500 participants across multiple studies [1][2]. STEP 1, the pivotal trial, demonstrated that 86.4% of participants achieved at least 5% weight loss, whilst 69.1% achieved 10% or more—outcomes rarely seen with lifestyle interventions alone [1].

STEP 2 specifically examined semaglutide in patients with type 2 diabetes, showing average weight reduction of 9.6% alongside improvements in glycaemic control [5]. This dual benefit makes Wegovy particularly valuable for patients managing both obesity and metabolic conditions, though it's important to note that Wegovy is licensed for weight management rather than diabetes treatment.

Long-term data from STEP 5 followed participants for 104 weeks, demonstrating sustained weight loss maintenance with continued treatment [2]. Participants who discontinued semaglutide experienced gradual weight regain, highlighting the importance of viewing Wegovy as part of a long-term weight management strategy rather than a short-term solution.

Managing Side Effects and Optimising Results

The most common side effects reported in clinical trials include nausea (44% of participants), diarrhoea (30%), vomiting (24%), and constipation (24%), typically occurring during dose escalation [3][4]. These gastrointestinal effects are usually mild to moderate and resolve within a few weeks as your body adjusts to each dose increase.

To minimise side effects, eat smaller meals more frequently, avoid high-fat foods that delay gastric emptying further, and stay well-hydrated throughout the day. Injecting Wegovy at the same time each week, preferably in the evening after your main meal, may also reduce nausea. If side effects persist or worsen, contact our clinical team—dose adjustments or temporary holds may be appropriate.

Optimising your results requires combining Wegovy with sustainable lifestyle modifications. Clinical trial participants followed reduced-calorie diets and increased physical activity, which contributed significantly to outcomes [1]. Our prescribers can provide guidance on evidence-based nutrition strategies and activity goals tailored to your current fitness level and any mobility limitations.

Regular monitoring is essential. Track your weight weekly, watch for signs of dehydration or persistent vomiting, and report any severe abdominal pain, vision changes, or signs of pancreatitis immediately. Your UK prescriber will schedule follow-up assessments to review your progress, adjust your treatment plan, and ensure you're achieving safe, sustainable weight loss.

When to Contact Your Prescriber

Seek immediate medical advice if you experience severe, persistent abdominal pain radiating to your back (possible pancreatitis), changes in vision, signs of thyroid nodules, or symptoms of severe dehydration [4]. Whilst serious side effects are rare, early recognition and management are crucial. Our clinical team at Cured Pharmacy is available via phone (+44 116 4646009) for any treatment concerns.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). Semaglutide (Wegovy): reports of suicidal and self-injurious thoughts. Drug Safety Update, 16(9). Retrieved from https://www.gov.uk/drug-safety-update [accessed 13 August 2026]
5. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine that must be prescribed by a qualified clinician following appropriate clinical assessment. Individual results may vary, and weight loss outcomes depend on multiple factors including diet, exercise, and adherence to treatment. Side effects can occur—refer to the patient information leaflet and speak with your prescriber about any concerns.